MedPath

Effect of Lavender Inhalation on Dysmenorrhea

Not Applicable
Recruiting
Conditions
Dysmenorrhea
Interventions
Other: Lavender oil inhalation
Other: Placebo
Registration Number
NCT05995730
Lead Sponsor
Saglik Bilimleri Universitesi
Brief Summary

This study was planned to determine the effect of lavender inhalation on primary dysmenorrhea and its symptoms.

Detailed Description

The research is a randomized controlled trial and an experimental research design will be used. The research will be carried out with two groups as experimental (lavender) and control (placebo) groups.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
51
Inclusion Criteria
  • Having primary dysmenorrhea (degrees II and III),
  • Single,
  • Who have never been pregnant before,
  • Having a regular menstrual cycle
  • Without any genital organ disorder (such as fibroids, fibroadenoma, endometriosis, metrorrhagia, ovarian cyst, pelvic inflammatory disease, chronic pelvic pain, other pelvic pathologies)
  • Not using contraceptive method,
  • Having a normal sense of smell
  • People who can smell odors and are not allergic to odors will be included in the study.
Exclusion Criteria
  • Married,
  • Having a disease that causes dysmenorrhea,
  • Regularly using a pharmacological and non-pharmacological method to relieve
  • Dysmenorrhea pain during the study,
  • Having a previous or unconcluded pregnancy,
  • Having a chronic disease (diabetes, endometriosis, uterine congenital anomalies, epilepsy, etc.),
  • Using drugs that affect the menstrual cycle or dysmenorrhea,
  • Persons who fill in the data collection form incompletely or not at all will not be included in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Experimental groupLavender oil inhalationLavender inhalation will be administered to this group.
Placebo groupPlaceboOlive oil will be administered to the placebo group.
Primary Outcome Measures
NameTimeMethod
Dysmenorrhea Symptom Assessment Formto assess post-intervention change; It is applied on the 1st, 2nd and 3rd days of the menstrual cycle during 2 menstrual cycles.

Form consists of questions about dysmenorrhea symptoms in the participants.As the score obtained from the form increases, the severity of the symptoms increases.

Numerical Pain Scaleto assess post-intervention change; It is applied on the 1st, 2nd and 3rd days of the menstrual cycle during 2 menstrual cycles.

It will be applied to evaluate the level of dysmenorrhea pain. Participants will be asked to rate their pain level from 0 to 10. As the score increases, the level of pain increases

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sakarya Training and Research Hospital

🇹🇷

Sakarya, Turkey

© Copyright 2025. All Rights Reserved by MedPath